Summit Global Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-3,000
Closed -$867K – 596
2021
Q3
$867K Sell
3,000
-8,320
-73% -$2.13M 0.07% 230
2021
Q2
$2.26M Buy
11,320
+641
+6% +$124K 0.14% 125
2021
Q1
$2.08M Sell
10,679
-3,093
-22% -$634K 0.13% 125
2020
Q4
$2.64M Sell
13,772
-1,174
-8% -$214K 0.26% 81
2020
Q3
$2.21M Buy
14,946
+12,046
+415% +$1.72M 0.23% 68
2020
Q2
$358K Buy
+2,900
New +$341K 0.04% 211

Other funds holding RGEN

Summit Global Investments's RGEN Position: Q4 2021 in Review

Summit Global Investments sold out of Repligen (RGEN) in Q4 2021, closing a stake of 3,000 shares — an estimated $867K sold.

Summit Global Investments first reported a position in RGEN in Q2 2020 and held it in 6 quarters. The position peaked at $2.64M in Q4 2020. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • Summit Global Investments reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 3,000 Repligen shares in Q4 2021, an estimated $867K.
  • Summit Global Investments first reported a position in Repligen in Q2 2020 and held it in 6 quarters.
  • Summit Global Investments's Repligen position peaked at $2.64M in Q4 2020.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.